RDIF and Minapharm Agree to Produce over 40 Million Doses of the Sputnik V Vaccine in Egypt
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary ProBioGen AG announce the agreement to produce over 40 million doses per…